To overcome this issue, we generated BCC clones that release PRL under the control of doxycycline, and found that SMI-6 induced rapid and dramatic suppression of PRL-induced tumor growth in athymic mice inoculated with such clones. Here, PRL is linked to skin basal cell carcinoma.